Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis - Université de Tours Accéder directement au contenu
Article Dans Une Revue European Journal of Pharmaceutics and Biopharmaceutics Année : 2018

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Dates et versions

hal-01919906 , version 1 (12-11-2018)

Identifiants

Citer

Sanaa Ben Djemaa, Stephanie David, Katel Hervé-Aubert, Annarita Falanga, Stefania Galdiero, et al.. Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis. European Journal of Pharmaceutics and Biopharmaceutics, 2018, 131, pp.99 - 108. ⟨10.1016/j.ejpb.2018.07.024⟩. ⟨hal-01919906⟩

Collections

UNIV-TOURS
52 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More